表紙SALE
市場調查報告書

感染監視解決方案的全球市場:各產品,感染疾病的各類型,各終端用戶,各地區的 競爭,預測,機會:2014年∼2025年

Global Infection Surveillance Solutions Market, By Product (Software (On-premise software Based, Web/Cloud Software) vs. Service), Infection Type, End User, Region, Competition, Forecast & Opportunities, 2014 - 2025

出版商 TechSci Research 商品編碼 940367
出版日期 內容資訊 英文 115 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

感染監視解決方案的全球市場:各產品,感染疾病的各類型,各終端用戶,各地區的 競爭,預測,機會:2014年∼2025年 Global Infection Surveillance Solutions Market, By Product (Software (On-premise software Based, Web/Cloud Software) vs. Service), Infection Type, End User, Region, Competition, Forecast & Opportunities, 2014 - 2025
出版日期: 2020年06月01日內容資訊: 英文 115 Pages
簡介

全球感染疾病監視解決方案市場,今後預計以16%的年複合成長率繼續成長,2025年一般認為將超越10億美元。

本報告提供全球感染監視解決方案市場調查,全球市場各地區市場展望,市場力學,主要的表示著趨勢,競爭情形等資訊,策略性建議。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球市場的展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品(軟體(Web /雲端基礎,內部部署為基礎)
    • 各類服務(產品支援,維修,訓練,諮詢,實行)
    • 感染疾病的各類型(手術部位感染疾病,泌尿道感染,血流感染疾病等)
    • 各終端用戶(醫院、診療所,門診病人手術中心,專門中心,看護設施)
    • 各地區
    • 各企業
  • 產品市場地圖

第6章 亞太地區市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 感染疾病的各類型
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他

第7章 歐洲市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 感染疾病的各類型
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 英國
    • 其他

第8章 北美市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 感染疾病的各類型
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 南美市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 感染疾病的各類型
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 其他

第10章 中東、非洲市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各產品
    • 感染疾病的各類型
    • 各終端用戶
    • 各國
  • 中東、非洲:各國分析
    • 沙烏地阿拉伯
    • UAE
    • 南非
    • 其他

第11章 市場力學

  • 成長促進因素
  • 課題

第12章 市場趨勢

第13章 競爭情形

  • Becton, Dickinson and Company
  • Baxter International Inc
  • Wolters Kluwer NV
  • Premier Inc.
  • Gojo Industries
  • BioVigil Healthcare Systems Inc
  • Medexter Healthcare GmbH
  • Koninklijke Philips NV
  • PeraHealth
  • Deb Group Ltd.
  • Cerner Corporation

第14章 策略性建議

目錄
Product Code: 4823

Global Infection Surveillance Solutions market is forecast to witness a CAGR of 16% and surpass $ 1 billion by 2025. Growth in the market can be attributed to rising healthcare expenditure, increasing number of surgeries, technological advancements in the field of healthcare IT, and growing awareness and accessibility to advanced healthcare facilities across the globe. Moreover, government policies and initiatives for the prevention of Healthcare-associated Infections (HAIs) are expected to continue boosting the adoption of infection surveillance solutions, globally.

The global infection surveillance solutions market can be segmented based on product, infection type, end user and region. In terms of product, the market is bifurcated into Software and Service. In 2019, software segment dominated the market, primarily due to higher adoption of infection surveillance software by healthcare facilities. The demand for software is higher than services due to technological advancements they offer for efficient management of patient data, analysis and interpretation.

Based on infection type, the market can be segmented into blood stream, urinary tract, surgical site and others. Urinary tract infection dominates the infection type segment, followed by surgical site and blood stream segments. In terms of end user, infection surveillance solutions market is segmented into hospitals & clinics, long term care facilities, ambulatory surgical centers and specialty centers. Hospitals & clinics are dominating the global market due to the high rate of admission of patients, increasing infections, and rise in the duration of patients staying at the hospitals.

Regionally, North America is the largest market for infection surveillance solutions and is expected to continue its dominance during the forecast period due to better healthcare facilities and higher awareness among patients about better healthcare services. Additionally, presence of major companies, continuous progress in healthcare settings and expansion of healthcare IT infrastructure are also driving the infection surveillance solutions market in this region. Asia Pacific is also expected to present lucrative opportunities in the coming years owing to the increasing efforts to avert HAIs and to improve overall healthcare facilities across the region.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global infection surveillance solutions market.
  • To classify and forecast global infection surveillance solutions market based on product, infection type, end user, and regional distribution.
  • To identify major drivers & challenges for global infection surveillance solutions market
  • To identify major emerging trends of global infection surveillance solutions market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global infection surveillance solutions market.
  • To identify and profile major companies operating in global infection surveillance solutions market.

To analyze and forecast global infection surveillance solutions market, both top down and bottom up approaches have been used. Multiple employees from several healthcare companies have been interviewed through telephonic conversations to extract and verify the information. A brief study of the major players operating in infection surveillance solutions market was conducted globally, which included the analysis of information such as technological advancements in the field of healthcare IT, followed by the detailed estimated investments in upcoming years in healthcare infrastructure, government funding and expenditure for the development of healthcare IT solution and various healthcare reforms and initiatives in different countries. Moreover, detailed and in-depth scrutiny of information was done to understand each policy or external or internal factor which could increase or decrease the demand for infection surveillance solutions globally.

Various secondary sources such as company websites, Annual Reports, White Papers, Investor Presentation, News Articles, Associations, were also studied by TechSci Research.

Key Target Audience

  • Infection surveillance solutions market players and other stakeholders
  • Major end users
  • Organizations, forums and alliances related to healthcare industry
  • Government bodies such as regulating authorities and policy makers
  • Market research and consulting firms

The study is essential in delivering useful information to industry stakeholders such as providers, vendors and end users. The report also provides useful insights about which market segments should be targeted over the coming years in order to strategize investments and capitalize on growth opportunities.

Report Scope

In this report, Global Infection Surveillance Solutions Market has been segmented into the following categories in addition to the industry trends which have also been detailed below:

  • Market, by Product:

Software

  • Web/Cloud Based
  • On-premise Based

Service

  • Product Support & Maintenance Services
  • Training & Consulting Services
  • Implementation Services
  • Market, by Infection Type:

Surgical Site

Urinary Tract

Blood Stream

Others

  • Market, by End User:

Hospitals & Clinics

Long-term Care Facilities

Ambulatory Surgical Centers

Specialty Centers

  • Market, by Region:

North America

  • US
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Colombia
  • Rest of South America

Middle East & Africa

  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global infection surveillance solutions market.

Voice of Customer: Monitor Safety, Identification of high-risk patients, and identification of care gaps for patients are the major factors affecting decision related to infection surveillance solutions for various users in the global infection surveillance solutions market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Channel Partner Analysis

  • Detailed list of distributors and dealers across all major regions.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Software (Web/Cloud Based & On-premise Based) vs. Service (Product Support & Maintenance Services, Training & Consulting Services, and Implementation Services)
    • 5.2.2. By Infection Type (Surgical Site Infection, Urinary Tract Infection, Blood Stream Infection and Others)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Centers, Long-term Care Facilities)
    • 5.2.4. By Region
    • 5.2.5. By Company (2019)
  • 5.3. Product Market Map

6. Asia-Pacific Infection Surveillance Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Infection Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Infection Surveillance Solutions Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Infection Type
        • 6.3.1.2.3. By End User
    • 6.3.2. India Infection Surveillance Solutions Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Infection Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Japan Infection Surveillance Solutions Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Infection Type
        • 6.3.3.2.3. By End User
    • 6.3.4. South Korea Infection Surveillance Solutions Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Infection Type
        • 6.3.4.2.3. By End User
    • 6.3.5. Rest of APAC Infection Surveillance Solutions Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Infection Type
        • 6.3.5.2.3. By End User

7. Europe Infection Surveillance Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Infection Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Infection Surveillance Solutions Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Infection Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Italy Infection Surveillance Solutions Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Infection Type
        • 7.3.2.2.3. By End User
    • 7.3.3. Spain Infection Surveillance Solutions Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Infection Type
        • 7.3.3.2.3. By End User
    • 7.3.4. France Infection Surveillance Solutions Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Infection Type
        • 7.3.4.2.3. By End User
    • 7.3.5. United Kingdom Infection Surveillance Solutions Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Infection Type
        • 7.3.5.2.3. By End User
    • 7.3.6. Rest of Europe Infection Surveillance Solutions Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product
        • 7.3.6.2.2. By Infection Type
        • 7.3.6.2.3. By End User

8. North America Infection Surveillance Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Infection Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Infection Surveillance Solutions Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Infection Type
        • 8.3.1.2.3. By End User
    • 8.3.2. Mexico Infection Surveillance Solutions Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Infection Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Canada Infection Surveillance Solutions Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Infection Type
        • 8.3.3.2.3. By End User

9. South America Infection Surveillance Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Infection Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Infection Surveillance Solutions Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Infection Type
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Infection Surveillance Solutions Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Infection Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Infection Surveillance Solutions Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Infection Type
        • 9.3.3.2.3. By End User
    • 9.3.4. Rest of South America Infection Surveillance Solutions Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Infection Type
        • 9.3.4.2.3. By End User

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Infection Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. Saudi Arabia Infection Surveillance Solutions Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Infection Type
        • 10.3.1.2.3. By End User
    • 10.3.2. UAE Infection Surveillance Solutions Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Infection Type
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Infection Surveillance Solutions Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Infection Type
        • 10.3.3.2.3. By End User
    • 10.3.4. Rest of MEA Infection Surveillance Solutions Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Infection Type
        • 10.3.4.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Becton, Dickinson and Company
  • 13.2. Baxter International Inc
  • 13.3. Wolters Kluwer NV
  • 13.4. Premier Inc.
  • 13.5. Gojo Industries
  • 13.6. BioVigil Healthcare Systems Inc
  • 13.7. Medexter Healthcare GmbH
  • 13.8. Koninklijke Philips NV
  • 13.9. PeraHealth
  • 13.10. Deb Group Ltd.
  • 13.11. Cerner Corporation

14. Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

List of Figures

  • Figure 1: Global Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 2: Global Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 3: Global Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 4: Global Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 5: Global Infection Surveillance Solutions Market Share, By Region, 2019 & 2025F
  • Figure 6: Global Infection Surveillance Solutions Market Share, By Company, 2019
  • Figure 7: North America Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 8: North America Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 9: North America Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 10: North America Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 11: North America Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
  • Figure 12: US Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 13: US Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 14: US Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 15: US Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 16: Canada Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 17: Canada Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 18: Canada Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 19: Canada Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 20: Mexico Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 21: Mexico Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 22: Mexico Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 23: Mexico Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 24: APAC Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 25: APAC Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 26: APAC Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 27: APAC Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 28: APAC Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
  • Figure 29: China Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 30: China Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 31: China Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 32: China Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 33: India Infection Surveillance Solutions Market Size, By Value, 2014-2025F (USD Million)
  • Figure 34: India Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 35: India Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 36: India Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 37: Japan Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 38: Japan Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 39: Japan Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 40: Japan Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 41: South Korea Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 42: South Korea Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 43: South Korea Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 44: South Korea Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 45: Rest of APAC Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 46: Rest of APAC Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 47: Rest of APAC Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 48: Rest of APAC Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 49: Europe Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 50: Europe Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 51: Europe Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 52: Europe Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 53: Europe Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
  • Figure 54: Germany Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 55: Germany Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 56: Germany Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 57: Germany Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 58: Italy Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 59: Italy Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 60: Italy Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 61: Italy Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 62: France Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 63: France Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 64: France Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 65: France Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 66: Spain Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 67: Spain Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 68: Spain Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 69: Spain Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 70: UK Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 71: UK Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 72: UK Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 73: UK Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 74: Rest of Europe Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 75: Rest of Europe Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 76: Rest of Europe Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 77: Rest of Europe Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 78: South America Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 79: South America Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 80: South America Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 81: South America Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 82: South America Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
  • Figure 83: Brazil Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 84: Brazil Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 85: Brazil Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 86: Brazil Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 87: Argentina Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 88: Argentina Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 89: Argentina Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 90: Argentina Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 91: Colombia Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 92: Colombia Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 93: Colombia Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 94: Colombia Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 95: Rest of South America Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 96: Rest of South America Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 97: Rest of South America Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 98: Rest of South America Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 99: Middle East & Africa Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 100: Middle East & Africa Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 101: Middle East & Africa Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 102: Middle East & Africa Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 103: Middle East & Africa Infection Surveillance Solutions Market Share, By Country, 2019 & 2025F
  • Figure 104: Saudi Arabia Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 105: Saudi Arabia Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 106: Saudi Arabia Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 107: Saudi Arabia Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 108: UAE Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 109: UAE Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 110: UAE Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 111: UAE Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 112: South Africa Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 113: South Africa Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 114: South Africa Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 115: South Africa Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F
  • Figure 116: Rest of Middle East & Africa Infection Surveillance Solutions Market Size, By Value, 2014-2025F, (USD Million)
  • Figure 117: Rest of Middle East & Africa Infection Surveillance Solutions Market Share, By Product, 2019 & 2025F
  • Figure 118: Rest of Middle East & Africa Infection Surveillance Solutions Market Share, By Infection Type, 2019 & 2025F
  • Figure 119: Rest of Middle East & Africa Infection Surveillance Solutions Market Share, By End User, 2019 & 2025F

List of Tables

  • Table 1: Global HealthCare Regulatory Initiatives and Policies, By Region/Country